Going To Sleep Is Free, But

""Pharmaceuticals valued at approximately $300 million (all amounts are expressed in U.S. dollars) were imported into Canada in 2002 [reference] from countries without mutual-recognition agreements about manufacturing practices. [reference] Twenty-five such countries (including China, India, Brazil, Hungary, Slovenia, Ecuador, Thailand, Croatia, Chile, South Africa, Argentina, and Indonesia) each exported $300,000 to $59 million worth of pharmaceuticals to Canada. [reference] In 2002, the value of imports from Thailand, Indonesia, Argentina, Ecuador, Chile, and Brazil were 264 percent, 296 percent, 500 percent, 501 percent, 512 percent, and 3270 percent higher, respectively, than they were in 1999. In the first three quarters of 2003, the value of imports from Iran increased to $1.5 million (a 2372 percent increase over the total value in 2002).

"Because drugs from Internet suppliers may originate outside Canada and the United States, neither government takes responsibility for their safety. Canada should take prompt action to prevent large-scale, unregulated, cross-border sales to avoid any negative outcomes from drugs whose origin is unclear and whose quality is unknown.""

""The mass exportation of prescription medication to the United States threatens the preferential pricing set by the Patented Medicine Prices Review Board.2 Companies may also choose not to market medication in Canada in order to protect the larger and more lucrative U.S. market.3 At risk is nothing less than the ability of countries to set their own policy regarding pharmaceuticals. The availability of Canadian medication is not a viable long-term solution to the problems of drug costs in the United States and represents a substantial threat to the access and affordability of drugs in Canada." [NEJM]"